id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-291505-vt5vpp60	Rusconi, Chiara	SARS-CoV-2 Interstitial Pneumonia Treated With Tocilizumab in a Patient Affected by Classical Hodgkin Lymphoma	2020-09-01		.txt	text/plain	1769	111	40	[5] [6] [7] We therefore report a case of SARS-CoV-2 interstitial pneumonia in a patient with classical Hodgkin Lymphoma (cHL) successfully treated with tocilizumab. 6, 7 More recently, a series of hematological cancer patients SARS-CoV-2 infected has been described: 3 out of 25 patients received tocilizumab, in 2 cases together with steroids, and a successful outcome has been reported for two of them. The first cHL patient affected by COVID-19 has been described by O'Kelly and colleagues: at symptoms onset, a PD-1 inhibitors induced pneumonitis was suspected, and treatment against SARS-CoV-2 was started after NPS test resulted positive. 14 To the best of our knowledge, this is the first extended report on successful tocilizumab treatment for a lymphoma patient affected by COVID-19; immunocompromised subjects may mount an antibody response and overcome SARS-CoV-2 infection, even in case of severe interstitial pneumonia.	./cache/cord-291505-vt5vpp60.txt	./txt/cord-291505-vt5vpp60.txt